Cantor, E., Wierzbicki, K., Tarapore, R. S., Ravi, K., Thomas, C., Cartaxo, R., Nand Yadav, V., Ravindran, R., Bruzek, A. K., Wadden, J., John, V., May Babila, C., Cummings, J. R., Rahman Kawakibi, A., Ji, S., Ramos, J., Paul, A., Walling, D., Leonard, M., Robertson, P., Franson, A., Mody, R., Garton, H. J. L., Venneti, S., Odia, Y., Kline, C., Vitanza, N. A., Khatua, S., Mueller, S., Allen, J. E., Gardner, S. L., & Koschmann, C. (2022). serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Neuro-oncology, 24(8), 1366–1374. http://access.bl.uk/ark:/81055/vdc_100160142282.0x000012